LifeStance Health EPS - Earnings per Share 2020-2023 | LFST
LifeStance Health eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| LifeStance Health Annual EPS | |
|---|---|
| 2023 | $-0.51 |
| 2022 | $-0.61 |
| 2021 | $-1.05 |
| 2020 | $-1.03 |
| 2019 | $0.00 |
| LifeStance Health Quarterly EPS | |
|---|---|
| 2023-12-31 | $-0.12 |
| 2023-09-30 | $-0.17 |
| 2023-06-30 | $-0.13 |
| 2023-03-31 | $-0.09 |
| 2022-12-31 | $-0.13 |
| 2022-09-30 | $-0.11 |
| 2022-06-30 | $-0.19 |
| 2022-03-31 | $-0.18 |
| 2021-12-31 | $-0.33 |
| 2021-09-30 | $-0.35 |
| 2021-06-30 | $-0.22 |
| 2021-03-31 | $-0.15 |
| 2020-12-31 | $-0.91 |
| 2020-09-30 | $-0.01 |
| 2020-06-30 | $-0.11 |
| 2020-03-31 | $0.00 |
| 2019-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.370B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
| Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
| DaVita (DVA) | United States | $11.709B | 15.93 |
| Chemed (CHE) | United States | $8.472B | 26.30 |
| Encompass Health (EHC) | United States | $8.259B | 21.25 |
| Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
| Option Care Health (OPCH) | United States | $5.147B | 19.48 |
| RadNet (RDNT) | United States | $3.314B | 96.80 |
| Amedisys (AMED) | United States | $2.999B | 21.25 |
| Astrana Health (ASTH) | United States | $2.057B | 25.68 |
| Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
| U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
| Pennant (PNTG) | United States | $0.624B | 36.46 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.323B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.014B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |